-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Working with Data Hub Data and Network PIs to Develop Evidence that Changes Practice in Multiple Myeloma: The COSMIC Study as Proof of Concept

Program: Special-Interest Sessions
Session: ASH Research Collaborative Multiple Myeloma Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation
Hematology Disease Topics & Pathways:
Research, Adult, Clinical Practice (Health Services and Quality), Elderly, Clinical Research, Health outcomes research, Bioinformatics, Patient-reported outcomes, Diseases, Real-world evidence, Registries, Lymphoid Malignancies, Technology and Procedures, Study Population, Human, Measurable Residual Disease
Saturday, December 7, 2024, 4:00 PM-5:30 PM

Saad Z. Usmani, MD

Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Disclosures: Usmani: Pfizer: Consultancy; Merck: Research Funding; SkylineDX: Consultancy, Research Funding; Takeda: Consultancy, Research Funding; Abbvie: Consultancy, Research Funding; Sanofi: Consultancy, Research Funding; Genentech: Consultancy; Amgen: Consultancy, Research Funding; Gilead: Research Funding; Bristol-Myers Squibb: Consultancy, Research Funding; Array Biopharma: Research Funding; SecuraBio: Consultancy; TeneoBio: Consultancy; SeaGen: Consultancy, Research Funding; Pharmacyclics: Research Funding; Gracell: Consultancy; Oncopeptides: Consultancy; Sanofi: Consultancy, Research Funding; GSK: Consultancy, Research Funding; Bristol-Myers Squibb - Celgene:: Consultancy, Research Funding; EdoPharma: Consultancy; Bristol-Myers Squibb - Celgene: Consultancy, Research Funding; Johnson & Johnson - Janssen: Consultancy, Research Funding.

See more of: ASH Research Collaborative Multiple Myeloma Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation >>